#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	17754	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2151	820.4	0	.	n	.	0	C1450T	SNP	1450	1450	C	1703	1703	T	979	T,C	731,171	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	17754	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2151	820.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1437	1437	C	1015	C	941	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	17754	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2151	820.4	0	HET	.	.	.	C207T,A	.	207	207	C	460	460	C	997	C,T,A	768,151,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	17754	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2151	820.4	0	HET	.	.	.	A658G	.	658	658	A	911	911	A	1000	A,G	666,281	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32608	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3633	894.8	0	.	n	.	0	T695C	SNP	695	695	T	1089	1089	C	922	C,T,A	864,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32608	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3633	894.8	0	.	n	.	0	A1638G	SNP	1638	1638	A	2032	2032	G	1055	G,A	995,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32608	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3633	894.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2365	2365	C	1006	C,T,A	924,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32608	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3633	894.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2439	2439	A	1037	A	988	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32608	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3633	894.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	2991	2991	C	1017	C	963	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2030	folP	855	855	100.0	folP.l6.c4.ctg.1	1589	127.4	1	SNP	p	R229S	1	.	.	685	687	AGC	1048	1050	AGC	219;218;217	A;G;C	206;206;206	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5388	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3296	162.3	1	SNP	p	S91F	1	.	.	271	273	TTC	562	564	TTC	199;200;200	T;T;C	184;184;184	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5388	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3296	162.3	1	SNP	p	D95G	1	.	.	283	285	GGC	574	576	GGC	201;204;205	G;G;C	186;190;189	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5388	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3296	162.3	1	SNP	p	G95N	0	.	.	283	285	GGC	574	576	GGC	201;204;205	G;G;C	186;190;189	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1672	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1550	107.6	1	SNP	p	G45D	0	.	.	133	135	GGC	601	603	GGC	205;205;208	G;G;C	187;188;192	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	936	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1200	77.7	0	.	n	.	0	A197.	DEL	197	197	A	667	667	A	210	A	198	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6720	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3069	218.2	1	SNP	p	D86N	0	.	.	256	258	GAC	642	644	GAC	250;252;253	G;A;C	230;228;236	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6720	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3069	218.2	1	SNP	p	R87I	0	.	.	259	261	CGT	645	647	CGT	252;248;250	C;G;T	238;230;231	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6720	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3069	218.2	1	SNP	p	S87R	1	.	.	259	261	CGT	645	647	CGT	252;248;250	C;G;T	238;230;231	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6720	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3069	218.2	1	SNP	p	R87W	0	.	.	259	261	CGT	645	647	CGT	252;248;250	C;G;T	238;230;231	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6720	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3069	218.2	1	SNP	p	S88P	0	.	.	262	264	TCC	648	650	TCC	252;252;249	T;C;C	235;235;235	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4290	parE	1986	1986	100.0	parE.l6.c30.ctg.1	2570	165.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1467	1469	GGC	191;187;184	G;G;C	178;173;171	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4360	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2401	180.6	1	SNP	p	A311V	0	.	.	931	933	GCC	1277	1279	GCC	229;225;226	G;C;C	210;208;206	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4360	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2401	180.6	1	SNP	p	I312M	1	.	.	934	936	ATG	1280	1282	ATG	230;231;230	A;T;G	215;215;213	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4360	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2401	180.6	1	SNP	p	V316T	1	.	.	946	948	ACC	1292	1294	ACC	221;222;220	A;C;C	203;209;206	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4360	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2401	180.6	1	SNP	p	T316P	0	.	.	946	948	ACC	1292	1294	ACC	221;222;220	A;C;C	203;209;206	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4360	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2401	180.6	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1793	1795	ACC	241;243;246	A;C;C	220;227;230	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4360	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2401	180.6	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1847	1849	GCG	265;263;266	G;C;G	242;240;245	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4360	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2401	180.6	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1847	1849	GCG	265;263;266	G;C;G	242;240;245	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4360	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2401	180.6	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1970	1972	GGT	202;201;196	G;G;T	184;180;177	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4360	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2401	180.6	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1979	1981	AGC	188;188;187	A;G;C	173;174;169	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4360	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2401	180.6	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1997	1999	CCG	163;165;166	C,G,T;C,G;G	119,6,1;125,2;128	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6924	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3187	216.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1672	1674	CCG	218;215;216	C;C;G	194;200;198	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2666	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1738	151.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	576	576	C	181	C	168	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3646	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1736	208.8	1	SNP	p	G120K	1	.	.	358	360	AAG	678	680	AAG	313;311;313	A;A;G,A	282;283;281,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3646	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1736	208.8	1	SNP	p	N121D	0	.	.	361	363	AAC	681	683	AAC	312;309;306	A;A;C,A	284;281;278,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3646	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1736	208.8	1	SNP	p	A121N	1	.	.	361	363	AAC	681	683	AAC	312;309;306	A;A;C,A	284;281;278,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	13672	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4838	281.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1532	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1083	140.7	1	SNP	p	V57M	1	.	.	169	171	ATG	549	551	ATG	321;324;320	A;T;G	303;305;300	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
